Compare Lionsgate Studios Corp Common Shares (LION) vs DENTSPLY SIRONA Inc (XRAY) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Lionsgate Studios Corp Common Shares vs DENTSPLY SIRONA Inc — how do they compare? Lionsgate Studios Corp Common Shares trades at $10.86 (market cap $3.24B), while DENTSPLY SIRONA Inc trades at $8.54 (market cap $1.68B). The key difference: Lionsgate Studios Corp Common Shares is the larger of the two by market cap, and DENTSPLY SIRONA Inc pays a 5.04% dividend while Lionsgate Studios Corp Common Shares pays none. Which is the better fit depends on your goals — on Pluang, investors hold Lionsgate Studios Corp Common Shares for 0 Days and DENTSPLY SIRONA Inc for 72 Days on average.
| LION | XRAY | |
|---|---|---|
Market Cap | $3.24B | $1.68B |
Volume | 3,214,595 | 3,968,929 |
Sector | Technology | Health |
52-Week High | $16.40 | $14.68 |
52-Week Low | $5.91 | $8.44 |
Typical Hold Time | 0 Days | 72 Days |
Enterprise Value | $6.75B | $3.76B |
Dividend Yield | — | 5.04% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
LION trades at $11.12, up 0.36% on the day, with a market cap of approximately $1.3 billion. The stock shows mixed signals: strong analyst support (87.5% buy rating) and a consensus price target of $16.80 suggest upside, but negative net income and shareholder equity highlight financial strain. Recent Q1 2027 earnings beat estimates with EPS of $0.37, yet the company remains unprofitable with a net loss of $128.5 million in 2025. Takeover interest from firms like Bolloré adds speculative appeal.
The outlook hinges on operational turnaround and potential M&A. Revenue growth from hit films like 'Michael' and a valuable content library offer catalysts, but high debt ($3.65B total) and consistent losses pose significant risks. Investors should weigh the 51% upside to price targets against fundamental weaknesses and industry volatility.
DENTSPLY SIRONA (XRAY) trades at $8.505, down 0.29% and near 52-week lows, with bearish technical signals and mixed fundamentals. The company reported Q2 2026 EPS of $0.52 beating estimates but faces declining revenue and negative margins. Recent news highlights institutional stake increases and ongoing restructuring efforts amid weak dental market conditions.
The stock presents a high-risk opportunity with analyst consensus at $12.50 (47% upside) but requires careful monitoring of margin recovery and sales stabilization. Key risks include persistent net losses, competitive pressures, and execution challenges in the turnaround plan.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Lionsgate Studios Corp Common Shares
Lionsgate Studios Corp. is a standalone content company that develops, finances, produces, and distributes motion pictures and television series, licensing its content to theaters, streaming platforms, television networks, and home entertainment channels.
Read more on LION →About DENTSPLY SIRONA Inc
Dentsply Sirona Inc is a global manufacturer and distributor of dental supplies and equipment. The company's operating segments include Technologies & Equipment, which is responsible for the design, manufacture, sales, and distribution of products including dental implants, CAD/CAM systems, orthodontic clear aligner products, imaging systems, treatment centers, instruments, as well as certain healthcare device products, primarily catheters
Read more on XRAY →
